A detailed history of Almitas Capital LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 1,988,563 shares of AMLX stock, worth $8.05 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
1,988,563
Previous 1,903,851 4.45%
Holding current value
$8.05 Million
Previous $3.62 Million 78.1%
% of portfolio
3.01%
Previous 1.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.65 - $3.24 $139,774 - $274,466
84,712 Added 4.45%
1,988,563 $6.44 Million
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.71 $3.08 Million - $5.16 Million
1,903,851 New
1,903,851 $3.62 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $237M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Almitas Capital LLC Portfolio

Follow Almitas Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almitas Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Almitas Capital LLC with notifications on news.